Bio-Path Holdings, Inc. (BPTH)
USD 0.67
(-6.95%)
USD 0.67
(-6.95%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -11.53 Million | -15.1 Million | -9.91 Million | -10.96 Million | -8.36 Million | -6.12 Million |
| Net Income | -16.07 Million | -13.86 Million | -10.44 Million | -10.88 Million | -8.59 Million | -8.58 Million |
| Depreciation & Amortization | 178 Thousand | 178 Thousand | 161 Thousand | 151 Thousand | 230 Thousand | 426 Thousand |
| Deferred income taxes | -227 Thousand | -507 Thousand | -1.34 Million | -963 Thousand | -1.31 Million | - |
| Stock-based compensation | 734 Thousand | 851 Thousand | 821 Thousand | 577 Thousand | 684 Thousand | 554 Thousand |
| Change in working capital | 3.36 Million | -2.26 Million | -459 Thousand | -806 Thousand | -676 Thousand | 871 Thousand |
| Other non-cash items | 498 Thousand | 507 Thousand | 1.34 Million | 963 Thousand | 1.31 Million | 608 Thousand |
| Investing Cash Flow | - | -21 Thousand | -70 Thousand | - | - | -17 Thousand |
| Investments in PPE | - | -21 Thousand | -70 Thousand | - | - | -17 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -21 Thousand | -70 Thousand | - | - | -17 Thousand |
| Financing Cash Flow | 2.2 Million | 1.73 Million | 20 Million | 4.28 Million | 27.78 Million | 1.18 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2.2 Million | 1.73 Million | 15.84 Million | 4.28 Million | 26.7 Million | 1.18 Million |
| Other Financing Activities | 2.2 Million | 1734.00 | 4.15 Million | 4289.00 | 1.08 Million | 1180.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 227 Thousand | 700 Thousand | -199 Thousand | -84 Thousand | -168 Thousand | 326 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -227 Thousand | -2.96 Million | -260 Thousand | -722 Thousand | -508 Thousand | 545 Thousand |
| Cash at beginning of period | 10.38 Million | 23.77 Million | 13.75 Million | 20.42 Million | 1 Million | 5.96 Million |
| Cash at end of period | 1.05 Million | 10.38 Million | 23.77 Million | 13.75 Million | 20.42 Million | 1 Million |
| Capital Expenditure | - | -21 Thousand | -70 Thousand | - | - | -17 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -9.33 Million | -13.39 Million | 10.01 Million | -6.67 Million | 19.42 Million | -4.96 Million |
| Free Cash Flow | -11.53 Million | -15.12 Million | -9.98 Million | -10.96 Million | -8.36 Million | -6.14 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.86 Million | -3.15 Million | -16.07 Million | -3.37 Million | -3.19 Million | -4.23 Million |
| Depreciation & Amortization | 32 Thousand | 47 Thousand | 178 Thousand | 41 Thousand | 46 Thousand | 46 Thousand |
| Deferred income taxes | - | - | -227 Thousand | 821 Thousand | - | -749 Thousand |
| Stock-based compensation | 141 Thousand | 170 Thousand | 734 Thousand | 180 Thousand | 178 Thousand | 170 Thousand |
| Change in working capital | -369 Thousand | 2.44 Million | 3.36 Million | 994 Thousand | 266 Thousand | 731 Thousand |
| Other non-cash items | -183 Thousand | -2.2 Million | 498 Thousand | 343 Thousand | -72 Thousand | 749 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 7.04 Million | 174 Thousand | 2.2 Million | 514 Thousand | 1.68 Million | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 7.04 Million | 174 Thousand | 2.2 Million | 514 Thousand | 1.68 Million | - |
| Other Financing Activities | 7.04 Million | 174 Thousand | 2.2 Million | 514 Thousand | 1.68 Million | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -775 Thousand | 1.92 Million | 227 Thousand | 562 Thousand | -72 Thousand | -487 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 406 Thousand | 513 Thousand | -227 Thousand | 432 Thousand | 338 Thousand | 1.21 Million |
| Cash at beginning of period | 188 Thousand | 1.05 Million | 10.38 Million | 2.35 Million | 3.44 Million | 6.73 Million |
| Cash at end of period | 4 Million | 188 Thousand | 1.05 Million | 1.05 Million | 2.35 Million | 3.44 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 3.81 Million | -864 Thousand | -9.33 Million | -1.3 Million | -1.09 Million | -3.28 Million |
| Free Cash Flow | -3.22 Million | -1.03 Million | -11.53 Million | -1.81 Million | -2.78 Million | -3.28 Million |
3791
MBGCF
UTL
EA
ROSSELLIND
BDL